Overview

Pharmacokinetic and Pharmacodynamic Study of Glufast Tablets 10mg(Mitiglinide)

Status:
Completed
Trial end date:
2018-04-01
Target enrollment:
Participant gender:
Summary
This clinical trial is designed to assess the effect of hepatic impairment on the pharmacokinetic and pharmacodynamic of glufast tablets 10 mg.
Phase:
Phase 4
Details
Lead Sponsor:
Orient Europharma Co., Ltd.
Treatments:
Mitiglinide